These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5346820)

  • 21. Resting levels of fibrinolysis in blood in inactive and exercising men.
    Moxley TR; Brakman P; Astrup T
    J Appl Physiol; 1970 May; 28(5):549-52. PubMed ID: 5442247
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemostatic alterations with exercise conditioning in NIDDM.
    Hornsby WG; Boggess KA; Lyons TJ; Barnwell WH; Lazarchick J; Colwell JA
    Diabetes Care; 1990 Feb; 13(2):87-92. PubMed ID: 2112452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effector mechanisms and products of the physiological fibrinolytic systems.
    Edgington TS; Plow EF
    Prog Clin Biol Res; 1976; 5():85-120. PubMed ID: 61595
    [No Abstract]   [Full Text] [Related]  

  • 24. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
    Agarwal S; Joyner KA; Swaim MW
    Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the blood fibrinolytic system in congestive cardiac failure.
    Rawles JM; Ogston D; Douglas AS
    Clin Sci; 1973 Jul; 45(1):65-76. PubMed ID: 4124172
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolytic activities of euglobulins precipitated at pH 6.4,6.0, and 5.3.
    Hedlin AM; Monkhouse FC
    Can J Physiol Pharmacol; 1969 Nov; 47(11):935-40. PubMed ID: 4242858
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis.
    Saito H; Goodnough LT; Boyle JM; Heimburger N
    Am J Med; 1982 Aug; 73(2):179-82. PubMed ID: 7114073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On coagulation and fibrinolysis in renal failure.
    Larsson SO
    Scand J Haematol Suppl; 1971; 15():1-59. PubMed ID: 5284430
    [No Abstract]   [Full Text] [Related]  

  • 29. Resting levels of blood fibrinolysis in hyperlipoproteinemia.
    Brakman P; Astrup T; Levy RI; Fredrickson DS
    J Appl Physiol; 1974 Apr; 36(4):430-3. PubMed ID: 4274385
    [No Abstract]   [Full Text] [Related]  

  • 30. Peripheral and gastric fibrinolysis in patients with gastric carcinoma.
    Prokopowicz J; Gabryelewicz A; Wołosowicz N; Szałaj W; Puchalski Z
    Z Exp Chir; 1975; 8(5):309-12. PubMed ID: 1053190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of poisoning on serum enzyme activities, coagulation, and fibrinolysis.
    Wright N; Clarkson AR; Brown SS; Fuster V
    Br Med J; 1971 Aug; 3(5770):347-50. PubMed ID: 5558188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia.
    Epstein SE; Brakman P; Rosing DR; Redwood DR
    Lancet; 1970 Sep; 2(7674):631-4. PubMed ID: 4195770
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fibrinolysis].
    Levy G; Michault A; Jamet M
    Ann Anesthesiol Fr; 1978; 19(8):703-8. PubMed ID: 31114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
    Comp PC; Jacocks RM; Rubenstein C; Radcliffe R
    J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PLASMA FIBRINOLYTIC ACTIVITY IN CIRRHOSIS OF THE LIVER.
    MATHUR KS; GUPTA DK; WAHAL PK
    J Indian Med Assoc; 1964 Aug; 43():103-7. PubMed ID: 14197937
    [No Abstract]   [Full Text] [Related]  

  • 37. Exercise induced increase in split products of fibrinogen.
    Ferguson EW; Nanninga LB
    Thromb Diath Haemorrh; 1970 Oct; 24(1):302-3. PubMed ID: 5483969
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of proteolytic and fibrinolytic factors in the human prostate.
    Nijs M; Brassinne C; Coune A; Tagnon HJ
    Thromb Diath Haemorrh; 1971 Jun; 25(3):481-98. PubMed ID: 4104828
    [No Abstract]   [Full Text] [Related]  

  • 39. Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.
    Hillenbrand P; Parbhoo SP; Jedrychowski A; Sherlock S
    Gut; 1974 Feb; 15(2):83-8. PubMed ID: 4820641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.